Mesa Laboratories Inc (MLAB)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	140,122	133,770	130,424	127,772	129,895	129,258	133,535	133,693	135,604	131,466	118,220	109,090	98,714	90,740	88,885	86,642	80,547	74,571	68,762	64,933
Revenue (ttm)	US$ in thousands	237,747	228,380	223,712	216,187	212,874	213,688	219,272	219,080	222,368	222,777	199,868	184,335	163,420	142,896	138,916	133,937	130,181	127,664	121,340	117,687
Gross profit margin		58.94%	58.57%	58.30%	59.10%	61.02%	60.49%	60.90%	61.02%	60.98%	59.01%	59.15%	59.18%	60.41%	63.50%	63.98%	64.69%	61.87%	58.41%	56.67%	55.17%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $140,122K ÷ $237,747K
= 58.94%

Mesa Laboratories Inc has displayed varying trends in its gross profit margin over the past few years, as indicated by the provided data. The gross profit margin, which represents the percentage of revenue left after deducting the cost of goods sold, has generally exhibited a positive trajectory from March 31, 2020, to December 31, 2021, experiencing incremental increases. The margin improved from 55.17% on March 31, 2020, to 61.87% on December 31, 2020, before reaching a peak of 64.69% on March 31, 2021.

However, starting from June 30, 2021, there was a slight decline observed in the gross profit margin, fluctuating between 60% and 64%. Notably, on June 30, 2022, the gross profit margin dipped to 59.15%, marking a notable decrease from the peak in the prior quarter. Nevertheless, Mesa Laboratories Inc managed to sustain the gross profit margin above 59% until December 31, 2023.

From March 31, 2024 onwards, Mesa Laboratories Inc experienced a gradual decrease in the gross profit margin, with fluctuations observed between 58% and 61%. Despite the slight volatility in recent periods, Mesa Laboratories Inc has largely maintained a gross profit margin above 55%, reflecting a healthy position in managing its cost of goods sold relative to its revenue. It will be essential for stakeholders to monitor the company's future performance to assess the impact of these fluctuations on its overall profitability and operational efficiency.